India’s Biologics Market To Hit $12 Billion By 2025 – Reports

Biologics and Biosimilars Industry in India is Growing Faster Than
Ever. India, now the emerging hub for biosimilars and biologics,
always possessed the skills to work on small molecules required to
make generic drugs. Still, they lacked the skills and environment to
develop reverse-engineered versions of biotech drugs. However, the
launch of 123 biosimilars, in […]

The post India's Biologics Market To Hit $12 Billion By 2025 – Reports
appeared first on BioTecNika .

https://www.biotecnika.org/2019/12/biologics-and-biosimilars-industry-in-india-is-growing-faster-than-ever/

Biotech News

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Politics of Making Poverty Visible in Brazil and Mexico